제닉
Financials
Valuation Metrics
제닉's Market Cap is ₩2000B. At end of 2025 it was ₩1316B. Ranked #854 of 2,421 in KR market (top 35%), #399 of 1,640 on KOSDAQ (top 24%), #22 of 57 in Household & Personal Products (top 39%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 200.01B KRW | KR#854/2,421 Sec#22/57 |
| Revenue | 114.29B KRW | KR#1,339/2,421 Sec#29/57 |
| Net Income | 26.06B KRW | KR#603/2,421 Sec#17/57 |
| Total Assets | 90.92B KRW | KR#1,854/2,421 Sec#38/57 |
| Net Assets | 55.79B KRW | KR#1,830/2,421 Sec#40/57 |
| Employees | 356 | KR#684/2,421 Sec#14/57 |
| Value | ||
| P/E | 7.67x | KR#633/2,421 Sec#9/57 |
| P/B | 3.59x | KR#2,156/2,421 Sec#50/57 |
| PEG | 0.10x | KR#419/2,421 Sec#12/57 |
| P/S | 1.75x | KR#1,725/2,421 Sec#43/57 |
| EV/EBITDA | 10.41x | KR#638/2,421 Sec#13/57 |
| FCF Yield | 8.99% | KR#643/2,421 Sec#11/57 |
| Profitability | ||
| ROE | 46.72% | KR#15/2,421 Sec#3/57 |
| ROA | 28.67% | KR#19/2,421 Sec#3/57 |
| Op. Margin | 16.76% | KR#240/2,421 Sec#5/57 |
| Revenue Growth | 48.33% | KR#219/2,421 Sec#6/57 |
| Earnings Growth | 74.70% | KR#453/2,421 Sec#15/57 |
| Financial Health | ||
| Debt Ratio | 62.97% | KR#1,133/2,421 Sec#31/57 |
| Total Debt | 3.00B KRW | KR#1,861/2,421 Sec#43/57 |
| FCF | 17.98B KRW | KR#547/2,421 Sec#13/57 |
| Cash | 3.66B KRW | KR#2,114/2,421 Sec#48/57 |
| Current Ratio | 1.83x | KR#959/2,421 Sec#26/57 |
| Net Debt/EBITDA | -0.03x | KR#601/2,421 Sec#19/57 |
| Performance | ||
| 1Y Return | -7.72% | KR#912/2,421 Sec#20/57 |
| 1M Return | -10.68% | KR#2,124/2,421 Sec#50/57 |
| From 52W High | -35.48% | KR#728/2,421 Sec#23/57 |
| 1Y MDD | -45.21% | KR#780/2,421 Sec#24/57 |
| Trading | ||
| Volume | 169,031 shares | KR#543/2,421 Sec#13/57 |
| Trading Value | 4.29B KRW | KR#396/2,421 Sec#12/57 |
| Foreign Own. | 4.20% | KR#1,001/2,421 Sec#18/57 |
| Per Share | ||
| EPS | 3,271 KRW | KR#318/2,421 Sec#9/57 |
| BPS | 7,001 KRW | KR#1,240/2,421 Sec#25/57 |
Company Info
Established in 2001 for the research, development, manufacturing, and sale of cosmetics and pharmaceuticals, the company was listed on KOSDAQ in 2011 and owns a wholly-owned sales corporation in China. Its core business revolves around R&D, manufacturing, and sales, leveraging its globally patented hydrogel technology. The company's brands are distributed through diverse channels, with online sales boosted by social media and influencer marketing. Increased product development and production requests reflect the acquisition of CGMP and various international certifications. Genic is headquartered in Seongnam-si, Gyeonggi-do.